Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 73

1.

Multibiomarker disease activity score and C-reactive protein in a cross-sectional observational study of patients with rheumatoid arthritis with and without concomitant fibromyalgia.

Lee YC, Hackett J, Frits M, Iannaccone CK, Shadick NA, Weinblatt ME, Segurado OG, Sasso EH.

Rheumatology (Oxford). 2016 Apr;55(4):640-8. doi: 10.1093/rheumatology/kev388. Epub 2015 Nov 25.

2.

Participation in clinical research registries: A focus group study examining views from patients with arthritis and other chronic illnesses.

Lee SB, Zak A, Iversen MD, Polletta VL, Shadick NA, Solomon DH.

Arthritis Care Res (Hoboken). 2015 Oct 16. doi: 10.1002/acr.22767. [Epub ahead of print]

PMID:
26474187
3.

Effects of Achieving Target Measures in Rheumatoid Arthritis on Functional Status, Quality of Life, and Resource Utilization: Analysis of Clinical Practice Data.

Alemao E, Joo S, Kawabata H, Al MJ, Allison PD, Rutten-van Mölken MP, Frits ML, Iannaccone CK, Shadick NA, Weinblatt ME.

Arthritis Care Res (Hoboken). 2016 Mar;68(3):308-17. doi: 10.1002/acr.22678.

PMID:
26238974
4.

The impact of multimorbidity status on treatment response in rheumatoid arthritis patients initiating disease-modifying anti-rheumatic drugs.

Radner H, Yoshida K, Frits M, Iannaccone C, Shadick NA, Weinblatt M, Smolen JS, Solomon DH.

Rheumatology (Oxford). 2015 Nov;54(11):2076-84. doi: 10.1093/rheumatology/kev239. Epub 2015 Jul 10.

PMID:
26163688
5.

Perceptions of physical activity engagement among adults with rheumatoid arthritis and rheumatologists.

Iversen MD, Scanlon L, Frits M, Shadick NA, Sharby N.

Int J Clin Rheumtol. 2015;10(2):67-77.

6.

Outcomes and costs of incorporating a multibiomarker disease activity test in the management of patients with rheumatoid arthritis.

Michaud K, Strand V, Shadick NA, Degtiar I, Ford K, Michalopoulos SN, Hornberger J.

Rheumatology (Oxford). 2015 Sep;54(9):1640-9. doi: 10.1093/rheumatology/kev023. Epub 2015 Apr 15.

7.

Detection of Rheumatoid Arthritis-Interstitial Lung Disease Is Enhanced by Serum Biomarkers.

Doyle TJ, Patel AS, Hatabu H, Nishino M, Wu G, Osorio JC, Golzarri MF, Traslosheros A, Chu SG, Frits ML, Iannaccone CK, Koontz D, Fuhrman C, Weinblatt ME, El-Chemaly SY, Washko GR, Hunninghake GM, Choi AM, Dellaripa PF, Oddis CV, Shadick NA, Ascherman DP, Rosas IO.

Am J Respir Crit Care Med. 2015 Jun 15;191(12):1403-12. doi: 10.1164/rccm.201411-1950OC.

PMID:
25822095
8.

Inconsistent treatment with disease-modifying antirheumatic drugs: a longitudinal data analysis.

Mjaavatten MD, Radner H, Yoshida K, Shadick NA, Frits ML, Iannaccone CK, Kvien TK, Weinblatt ME, Solomon DH.

J Rheumatol. 2014 Dec;41(12):2370-8. doi: 10.3899/jrheum.140306. Epub 2014 Oct 15.

9.

Clinical characteristics of RA patients with secondary SS and association with joint damage.

Brown LE, Frits ML, Iannaccone CK, Weinblatt ME, Shadick NA, Liao KP.

Rheumatology (Oxford). 2015 May;54(5):816-20. doi: 10.1093/rheumatology/keu400. Epub 2014 Oct 13.

PMID:
25313147
10.

Do rheumatologists know best? An outcomes study of inconsistent users of disease-modifying anti-rheumatic drugs.

Mjaavatten MD, Radner H, Yoshida K, Shadick NA, Frits ML, Iannaccone CK, Kvien TK, Weinblatt ME, Solomon DH.

Semin Arthritis Rheum. 2015 Feb;44(4):399-404. doi: 10.1016/j.semarthrit.2014.08.003. Epub 2014 Aug 27.

11.

Behavioral and clinical factors associated with self-reported abnormal Papanicolaou tests in rheumatoid arthritis.

Gillet VG, Solomon DH, Shadick NA, Weinblatt ME, Iannaccone CK, Feldman S, Kim SC.

J Womens Health (Larchmt). 2014 Sep;23(9):771-6. doi: 10.1089/jwh.2013.4658.

12.

Subgrouping of patients with rheumatoid arthritis based on pain, fatigue, inflammation, and psychosocial factors.

Lee YC, Frits ML, Iannaccone CK, Weinblatt ME, Shadick NA, Williams DA, Cui J.

Arthritis Rheumatol. 2014 Aug;66(8):2006-14. doi: 10.1002/art.38682.

13.

The influence of polygenic risk scores on heritability of anti-CCP level in RA.

Cui J, Taylor KE, Lee YC, Källberg H, Weinblatt ME, Coblyn JS, Klareskog L, Criswell LA, Gregersen PK, Shadick NA, Plenge RM, Karlson EW.

Genes Immun. 2014 Mar;15(2):107-14. doi: 10.1038/gene.2013.68. Epub 2014 Jan 2.

14.

Functional impact of a spectrum of interstitial lung abnormalities in rheumatoid arthritis.

Doyle TJ, Dellaripa PF, Batra K, Frits ML, Iannaccone CK, Hatabu H, Nishino M, Weinblatt ME, Ascherman DP, Washko GR, Hunninghake GM, Choi AM, Shadick NA, Rosas IO.

Chest. 2014 Jul;146(1):41-50. doi: 10.1378/chest.13-1394.

15.

Associations of smoking and alcohol consumption with disease activity and functional status in rheumatoid arthritis.

Lu B, Rho YH, Cui J, Iannaccone CK, Frits ML, Karlson EW, Shadick NA.

J Rheumatol. 2014 Jan;41(1):24-30. doi: 10.3899/jrheum.130074. Epub 2013 Dec 1.

16.

Automatic prediction of rheumatoid arthritis disease activity from the electronic medical records.

Lin C, Karlson EW, Canhao H, Miller TA, Dligach D, Chen PJ, Perez RN, Shen Y, Weinblatt ME, Shadick NA, Plenge RM, Savova GK.

PLoS One. 2013 Aug 16;8(8):e69932. doi: 10.1371/journal.pone.0069932. eCollection 2013.

17.

A randomized controlled trial of an internal family systems-based psychotherapeutic intervention on outcomes in rheumatoid arthritis: a proof-of-concept study.

Shadick NA, Sowell NF, Frits ML, Hoffman SM, Hartz SA, Booth FD, Sweezy M, Rogers PR, Dubin RL, Atkinson JC, Friedman AL, Augusto F, Iannaccone CK, Fossel AH, Quinn G, Cui J, Losina E, Schwartz RC.

J Rheumatol. 2013 Nov;40(11):1831-41. doi: 10.3899/jrheum.121465. Epub 2013 Aug 15.

18.

Development of a multi-biomarker disease activity test for rheumatoid arthritis.

Centola M, Cavet G, Shen Y, Ramanujan S, Knowlton N, Swan KA, Turner M, Sutton C, Smith DR, Haney DJ, Chernoff D, Hesterberg LK, Carulli JP, Taylor PC, Shadick NA, Weinblatt ME, Curtis JR.

PLoS One. 2013 Apr 9;8(4):e60635. doi: 10.1371/journal.pone.0060635. Print 2013. Erratum in: PLoS One. 2014;9(6):e99812.

19.

Genome-wide association study and gene expression analysis identifies CD84 as a predictor of response to etanercept therapy in rheumatoid arthritis.

Cui J, Stahl EA, Saevarsdottir S, Miceli C, Diogo D, Trynka G, Raj T, Mirkov MU, Canhao H, Ikari K, Terao C, Okada Y, Wedrén S, Askling J, Yamanaka H, Momohara S, Taniguchi A, Ohmura K, Matsuda F, Mimori T, Gupta N, Kuchroo M, Morgan AW, Isaacs JD, Wilson AG, Hyrich KL, Herenius M, Doorenspleet ME, Tak PP, Crusius JB, van der Horst-Bruinsma IE, Wolbink GJ, van Riel PL, van de Laar M, Guchelaar HJ, Shadick NA, Allaart CF, Huizinga TW, Toes RE, Kimberly RP, Bridges SL Jr, Criswell LA, Moreland LW, Fonseca JE, de Vries N, Stranger BE, De Jager PL, Raychaudhuri S, Weinblatt ME, Gregersen PK, Mariette X, Barton A, Padyukov L, Coenen MJ, Karlson EW, Plenge RM.

PLoS Genet. 2013 Mar;9(3):e1003394. doi: 10.1371/journal.pgen.1003394. Epub 2013 Mar 28.

20.

Performance of matrix-based risk models for rapid radiographic progression in a cohort of patients with established rheumatoid arthritis.

Lillegraven S, Paynter N, Prince FH, Shadick NA, Haavardsholm EA, Frits ML, Iannaccone CK, Kvien TK, Weinblatt ME, Solomon DH.

Arthritis Care Res (Hoboken). 2013 Apr;65(4):526-33. doi: 10.1002/acr.21870.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk